NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174
Trxade Group (NASDAQ: MEDS) has continued to offer innovative medical consultation and prescription drug solutions and was answering today’s health care demands well ahead of COVID-19. Even before emergence of the pandemic, Trxade Group was introducing services that help independent pharmacies shop competitively for medications as well as help patients receive those medications promptly and safely and access medical providers through smart-tech secured applications. The company has further advanced measures to assist patients and providers continue to access resources through a virtual environment, all while its business model is gaining ground amid increased demand. A recent article discussing pandemic-driven growth of virtual health care reads, “During the COVID-19 crisis, telehealth services have seen astronomical expansion. Telehealth claims to private insurers have grown 4,347% year-over-year (http://nnw.fm/KdQP2), CVS Health saw 600% growth in telehealth and virtual visits through its MinuteClinics in the first quarter of 2020 (http://nnw.fm/iabaP), Blue Cross and Blue Shield of Tennessee saw 50 times more telehealth visits in May compared to their normal amount (http://nnw.fm/HoW3M), and Blue Cross of Idaho processed more than 90,500 telehealth claims between March and June, with telehealth now representing more than one-quarter of all claims (http://nnw.fm/z9xpo).”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer